The results of an in vivo experiment conducted by Yue et al. demonstrated that different doses of atorvastatin could alleviate kidney injury as well as reduce apoptosis and inflammatory factor levels (IL-1β, IL-6 and MCP-1) in the kidneys of CI-AKI rats [8]. Here, IL1B is linked to acute kidney injury.